Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Innovita Biological Technology Co., Ltd.

Market Cap 8.09B 1.2B 1.03B 951M 891M 1.67B 114B 1.69B 11.23B 4.38B 55.31B 4.49B 4.39B 192B P/E Ratio 2026 *
62.2x
P/E Ratio 2027 * 56.7x
Enterprise Value 8.09B 1.2B 1.03B 951M 891M 1.67B 114B 1.69B 11.23B 4.38B 55.31B 4.49B 4.39B 192B EV / Sales 2026 *
22x
EV / Sales 2027 * 20.3x
Free-Float
41.51%
Yield 2026 *
-
Yield 2027 * -
1 day+2.05%
1 week+0.35%
Current month+5.94%
1 month-3.65%
3 months+47.94%
6 months+85.73%
Current year+91.52%
1 week 53
Extreme 53
58.91
1 month 53
Extreme 53
68.5
Current year 30.1
Extreme 30.1
68.5
1 year 29.99
Extreme 29.99
68.5
3 years 19.12
Extreme 19.12
68.5
5 years 19.12
Extreme 19.12
68.5
10 years 19.12
Extreme 19.12
68.5
Manager TitleAgeSince
Chief Executive Officer 55 05/02/2006
Director of Finance/CFO 52 31/12/2019
Chief Tech/Sci/R&D Officer 53 31/03/2006
Director TitleAgeSince
Director/Board Member 49 08/11/2020
Director/Board Member 44 08/11/2020
Director/Board Member 57 30/11/2019
Date Insider Type Main position Quantity % Market Cap.
05-25Sell -10,000 0.0335%
11-03Sell 5,240 0.0175%
22/10/25Sell 1,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.05%+0.35%+87.78%+135.82% 1.15B
-0.20%+4.78%+167.03%+246.32% 17.45B
+0.22%-6.15%-43.79%-26.20% 9.25B
-0.86%+3.51%+34.29%+21.25% 6.8B
+2.45%+8.98% - - 5.08B
-0.39%-2.02%-27.97%-27.87% 5.06B
+1.11%-4.35%-28.45%-31.22% 4.08B
-1.36%-13.84%+68.37%+66.53% 3.77B
+5.58%-7.09%+176.91%-49.95% 3.66B
+0.64%+0.51%-16.55%-41.22% 2.64B
Average +1.00%-0.73%+46.40%+32.61% 5.89B
Weighted average by Cap. +0.53%-0.04%+64.01%+75.15%

Financials

2026 *2027 *
Net sales 367M 54.28M 46.88M 43.2M 40.44M 75.79M 5.16B 76.96M 510M 199M 2.51B 204M 199M 8.7B 398M 58.76M 50.75M 46.77M 43.78M 82.04M 5.59B 83.31M 552M 215M 2.72B 221M 216M 9.41B
Net income 127M 18.78M 16.22M 14.95M 13.99M 26.22M 1.79B 26.63M 176M 68.81M 869M 70.48M 68.98M 3.01B 140M 20.73M 17.9M 16.5M 15.44M 28.94M 1.97B 29.39M 195M 75.96M 959M 77.8M 76.14M 3.32B
Net Debt - -
Logo Innovita Biological Technology Co., Ltd.
Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of in vitro diagnostic rapid diagnostic products. The Company's main products include whole blood respiratory tract marker 5-item test kits, influenza antigen 3-item test kits, influenza antibody 3-item test kits, serum respiratory tract marker 5-item test kits, respiratory fluorescence 9-item test kits and others. These products are mainly used for the detection of respiratory pathogens, gastrointestinal pathogens, hepatitis diagnostics and others. The Company mainly conducts its business in the domestic and overseas markets.
Employees
571
Date Price Change Volume
12/06/26 57.80 ¥ +2.05% 2,001,965
11/06/26 56.64 ¥ +1.54% 1,632,745
10/06/26 55.78 ¥ +1.92% 1,456,085
09/06/26 54.73 ¥ +0.24% 1,685,179
08/06/26 54.60 ¥ -5.21% 2,078,941
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
57.80CNY
Average target price
53.81CNY
Spread / Average Target
-6.90%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 688253 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!